跳至主要内容
临床试验/NCT01385982
NCT01385982已完成3 期

Improving Management of Outpatient Actionable Test Results

Brigham and Women's Hospital2 个研究点 分布在 1 个国家目标入组 6,000 人开始时间: 2011年7月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
6,000
试验地点
2
主要终点
Acknowledged Sub-Critical/Abnormal ATRs

研究概览

简要总结

Clinically significant test results require timely clinician follow-up including the non-urgent clinically significant, or actionable, test results that have received less standardized management and attention. Unfortunately, failure to correctly manage actionable test results is not infrequent and may be associated with important delays in diagnosis and treatment and patient harm. The investigators have designed a safe practice intervention to improve the management of actionable test results for ambulatory patients in a large healthcare system.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary care physicians will be enrolled in the study by virtue of being an actively practicing clinician in an PHS ambulatory practice, and having at least one patient with a diagnostic test included in the PHS CCSTR intervention. The patient population will consist of adult patients >17 years of age with diagnostic tests in the affiliated ambulatory practices of PHS. Patients will be recruited into the study by a review of electronic medical record data to identify patients with a diagnostic test specified in the PHS CCSTR intervention.

排除标准

  • Participants who do not meet the inclusion/eligibility requirements will be excluded.

结局指标

主要结局

Acknowledged Sub-Critical/Abnormal ATRs

时间窗: Acknowledgement within 15 business days from the Level 3 Laboratory ATR alert and acknowledgement within 8 business hours of the cardiology Level 2 ATR alert

The primary outcome of interest is the proportion of sub-critical/abnormal (Level 3 Laboratory and Level 2 Cardiology) ATRs documented as acknowledged by the responsible clinician and having appropriate, follow-up action(s).

次要结局

  • Undiagnosed/Untreated Condition Frequency and Severity(Minumum of 3 months post ATR)
  • Diagnosis and/or Treatment Delays(Minumum of 3 months post ATR)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeffrey Rothschild, MD

Hospitalist

Brigham and Women's Hospital

研究点 (2)

Loading locations...

相似试验